
Sign up to save your podcasts
Or


Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
By JAMA Network4.2
1919 ratings
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

43,653 Listeners

136 Listeners

317 Listeners

695 Listeners

498 Listeners

162 Listeners

762 Listeners

6,418 Listeners

296 Listeners

3,342 Listeners

38 Listeners

21 Listeners

12 Listeners

11 Listeners

9 Listeners

16 Listeners

5 Listeners

7 Listeners

1,147 Listeners

30 Listeners

9 Listeners

94 Listeners

14 Listeners

5 Listeners

512 Listeners

5 Listeners

367 Listeners

106 Listeners

18 Listeners

3 Listeners